Comparison of a Small Dose of Oxycodone and Sufentanil for the Prevention of Sufentanil-Induced Cough during General Anesthesia Induction: A Prospective Randomized Controlled Trial.
Journal
Computational and mathematical methods in medicine
ISSN: 1748-6718
Titre abrégé: Comput Math Methods Med
Pays: United States
ID NLM: 101277751
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
04
2022
revised:
01
06
2022
accepted:
03
06
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
29
6
2022
Statut:
epublish
Résumé
Sufentanil is widely used during anesthesia induction. However, it can cause coughing via different mechanisms. This study is aimed at evaluating the effectiveness of a small dose of oxycodone and sufentanil in suppressing sufentanil-induced cough (SIC) during general anesthesia induction. Of the 174 patients scheduled for elective surgery, 144 were eligible and randomly divided into 3 groups ( The incidences of cough in group N, group O, and group S were 20 (41.6%), 7 (14.5%), and 6 (12.5%), respectively. Compared with group N, patients from group O and group S exhibited significantly reduced incidence and severity of cough, and the severity of cough in group O and group S was significantly reduced compared with group N (
Sections du résumé
Background
UNASSIGNED
Sufentanil is widely used during anesthesia induction. However, it can cause coughing via different mechanisms. This study is aimed at evaluating the effectiveness of a small dose of oxycodone and sufentanil in suppressing sufentanil-induced cough (SIC) during general anesthesia induction.
Methods
UNASSIGNED
Of the 174 patients scheduled for elective surgery, 144 were eligible and randomly divided into 3 groups (
Results
UNASSIGNED
The incidences of cough in group N, group O, and group S were 20 (41.6%), 7 (14.5%), and 6 (12.5%), respectively. Compared with group N, patients from group O and group S exhibited significantly reduced incidence and severity of cough, and the severity of cough in group O and group S was significantly reduced compared with group N (
Identifiants
pubmed: 35756420
doi: 10.1155/2022/7924643
pmc: PMC9232308
doi:
Substances chimiques
Sufentanil
AFE2YW0IIZ
Oxycodone
CD35PMG570
Types de publication
Journal Article
Randomized Controlled Trial
Retracted Publication
Langues
eng
Sous-ensembles de citation
IM
Pagination
7924643Commentaires et corrections
Type : RetractionIn
Informations de copyright
Copyright © 2022 Lingli Shi et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Can J Anaesth. 2003 Mar;50(3):297-300
pubmed: 12620955
BMC Anesthesiol. 2019 Jun 1;19(1):89
pubmed: 31153360
Int J Clin Exp Med. 2014 Apr 15;7(4):826-36
pubmed: 24955151
Korean J Anesthesiol. 2013 Sep;65(3):251-3
pubmed: 24101960
BMC Anesthesiol. 2019 Aug 28;19(1):164
pubmed: 31455295
Trials. 2019 Mar 15;20(1):170
pubmed: 30876430
BMC Anesthesiol. 2020 Jun 22;20(1):154
pubmed: 32571219
Middle East J Anaesthesiol. 2014 Jun;22(5):449-56
pubmed: 25137861
Pharmacol Rep. 2015 Feb;67(1):52-5
pubmed: 25560575
J Appl Physiol (1985). 1988 Sep;65(3):1007-23
pubmed: 3053580
Int J Clin Pract. 2020 Dec;74(12):e13642
pubmed: 32741071
BMC Anesthesiol. 2018 Apr 10;18(1):38
pubmed: 29636004
J Anesth. 2013 Feb;27(1):25-8
pubmed: 22923258
Anaesthesia. 2010 Jan;65(1):4-7
pubmed: 19889113
Anesthesiology. 1997 Nov;87(5):1070-4
pubmed: 9366458
Anesth Analg. 1978 Jan-Feb;57(1):31-6
pubmed: 564641
J Perianesth Nurs. 2019 Dec;34(6):1181-1186
pubmed: 31262573
J Invest Surg. 2019 Aug;32(5):428-432
pubmed: 29388856
Anaesthesia. 2010 Jul;65(7):697-703
pubmed: 20477784
Can J Anaesth. 2004 Aug-Sep;51(7):654-9
pubmed: 15310631
BMC Anesthesiol. 2020 Aug 17;20(1):205
pubmed: 32799792
Anaesthesia. 2007 Dec;62(12):1230-2
pubmed: 17991258
Ther Clin Risk Manag. 2020 Apr 14;16:281-286
pubmed: 32341646
J Craniofac Surg. 2019 Nov-Dec;30(8):2499-2501
pubmed: 31567764
Int J Clin Exp Med. 2015 Aug 15;8(8):13864-8
pubmed: 26550339